Navigation Links
Mother-Child Death Rates Down But Still Short of 2015 Goal
Date:9/21/2011

WEDNESDAY, Sept. 21 (HealthDay News) -- Mother and child death rates are declining faster than in the previous decade in more than half the countries around the world, an indication that international efforts to improve mother and child health are having an effect, researchers say.

But despite the progress, it appears that few countries will meet the 2015 Millennium Developmental Goals for saving the lives of mothers and children, according to the team at the Institute for Health Metrics and Evaluation at the University of Washington in Seattle.

Countries worldwide that signed the Millennium Declaration in 2000 promised to make improvements in child and mother health through programs to educate more women and to prevent infectious diseases in developing countries.

The researchers' analysis found that death rates among mothers in 125 countries and death rates among children in 106 countries declined faster between 2000 and 2011 than in the previous decade. Progress has been particularly strong in the past five years, the researchers said in a university news release.

Between 1990 and 2011, the number of deaths worldwide related to pregnancy and childbirth decreased from 409,100 to 273,500, and the number of deaths among children under the age of 5 fell from 11.6 million to 7.2 million.

The researchers estimated that 31 developing countries will achieve Millennium Development Goal 4, which calls for a two-thirds reduction in the child death rate between 1990 and 2015, and 13 developing countries will achieve Millennium Development Goal 5, which calls for a three-fourths reduction in women's deaths due to pregnancy and childbirth.

The analysis suggested that nine countries will achieve both goals: China, Egypt, Iran, Libya, Maldives, Mongolia, Peru, Syria and Tunisia.

The study, published online Sept. 20 in The Lancet, concluded that "immediate concerted action is needed" for many countries
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

0

GOOD

Page: 1 2

Related medicine news :

1. Living in poor neighborhood a risk factor for out-of-hospital cardiac death
2. Hospitals Serving More Minorities Have Higher Trauma Death Rate
3. Gene Variant May Raise Death Risk After Heart Bypass
4. Heavy Drinking Ups Odds of Death in House Fire
5. Losing Child in First Year Might Raise Early Death Risk for Parent
6. Obesity and large waist size linked to higher risk of death in African-American women
7. Even mild cognitive impairment appears to substantially increase risk for death
8. Bacterial Strain Behind Black Death Plague Is Likely Extinct: Study
9. Blood Protein Might Signal Death Risk in Elderly
10. Statins reduce deaths from infection and respiratory illness, 8 years on from trial
11. Insulation from public pressure leads to more accurate suicide reporting by death investigators
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Mother-Child Death Rates Down But Still Short of 2015 Goal
(Date:5/23/2013)... who eat at fast-food restaurants are consuming significantly more ... worst offenders, a new study found. "Teens underestimate ... much as 34 percent, parents of school-age children by ... much as 20 percent," study lead researcher, Dr. Jason ... Wood Johnson Foundation, which helped fund the study. ...
(Date:5/23/2013)... when a woman harried by hot flashes says she,s ... published online in Menopause , the journal of ... objective tests that what these women say about their ... showed that hot flashes were related to memory problems, ... there was a relationship between hot flashes and what ...
(Date:5/23/2013)... 2013 “Talk. They Hear You.” a ... parents to talk to children as young as nine ... launched today by the Substance Abuse and Mental Health ... conjunction with SAMHSA’s 2013 National Prevention Week—an annual health ... substance abuse and mental health issues. , SAMHSA’s latest ...
(Date:5/23/2013)... May 23, 2013 Live ... contemporary services, provides the best business lead solution ... Its Call center Management solution features Free Web ... Call Limitation, Do-Not-Call Maintenance and "Automatic Transfer Retry". ... comprehensive campaign delivery and management system. , Its ...
(Date:5/23/2013)... be tested in a clinical trial by a biomedical ... disease has failed to work with the same type ... results of a study by University of Florida researchers. ... with the Evelyn F. and William L. McKnight Brain ... of verifying promising research results before investing in clinical ...
Breaking Medicine News(10 mins):Health News:How Many Calories in Your Fast-Food Meal? Guess Again 2Health News:New Campaign to Help Parents Talk to Younger Children About the Dangers of Underage Drinking 2Health News:Live Lead Pros Announces The Benefits of Comprehensive Campaign Delivery and Management System 2Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 2Health News:Anti-cancer drug viewed as possible Alzheimer's treatment doesn't work in UF study 3
... WASHINGTON, Dec. 18 - In response to the,press ... E. Schumer (D-NY) of a bill -- S ... (DARA 2007)," -- which proposes to amend,the Controlled ... to minors and,create penalties to those who would ...
... America, the,fastest-growing Hispanic television network in the United States, ... this week,s broadcast of "Issues:,Caras y Voces" (Issues: Faces ... Dr. Huerta is the first Latino to assume the ... studied medicine at the University of San,Marcos and Johns ...
... Dec. 18 /PRNewswire-FirstCall/ - Aspreva Pharmaceuticals,Corporation (NASDAQ: ... British,Columbia Supreme Court has issued a final order ... (SWX: GALN), through a wholly-owned,Canadian subsidiary, will acquire ... US$26.00 per share in cash., The transaction, ...
... 18 Alsius Corporation,(Nasdaq: ALUS ), which ... announced today that the company has,launched offers to ... opportunity, for a limited time, to exercise the ... terms of the warrants to allow holders to,receive ...
... Royalty Pharma and Northwestern,University announced today that Northwestern ... in Lyrica(R) to Royalty Pharma for $700 million,in ... A portion of the payment to Northwestern will ... chemical compound that serves as the basis for,Lyrica(R)., ...
... SAN DIEGO, Dec. 18 Pacira Pharmaceuticals, ... today announced that,David M. Stack has been ... of the Board of Directors., (Logo: ... currently the CEO and founding partner of ...
Cached Medicine News:Health News:Council for Responsible Nutrition Calls Proposed DHEA Legislation 'A Solution in Search of a Problem' 2Health News:American Cancer Society President Elmer Huerta Shares Inspirational Message on Azteca America's 'Issues: Caras Y Voces' 2Health News:Aspreva receives final court approval for acquisition by Galenica 2Health News:Aspreva receives final court approval for acquisition by Galenica 3Health News:Aspreva receives final court approval for acquisition by Galenica 4Health News:Alsius Corporation Announces Program for Early Exercise of Warrants 2Health News:Alsius Corporation Announces Program for Early Exercise of Warrants 3Health News:Alsius Corporation Announces Program for Early Exercise of Warrants 4Health News:Royalty Pharma Acquires a Portion of Northwestern University's Royalty Interest in Lyrica(R) for $700 Million 2Health News:Royalty Pharma Acquires a Portion of Northwestern University's Royalty Interest in Lyrica(R) for $700 Million 3Health News:Pacira Pharmaceuticals Names David M. Stack CEO and President 2Health News:Pacira Pharmaceuticals Names David M. Stack CEO and President 3
(Date:5/23/2013)... -- BioElectronics Corporation (OTC Pink: BIEL), the maker of very ... panel meeting for non-thermal shortwave diathermy: The ... Meeting was held on May 21, 2013 in ... the meeting was very narrow, in that the FDA ... application of non-thermal shortwave diathermy for the treatment of ...
(Date:5/23/2013)... 23, 2013  Intercept Pharmaceuticals, Inc. (Nasdaq: ... on the development and commercialization of novel bile acid ... biliary cirrhosis, today announced that Mark Pruzanski ... present at the Deutsche Bank Securities 38th Annual Health ... Wednesday, May 29, 2013 at 4:10 p.m. ET. ...
(Date:5/23/2013)...  Inhibikase Therapeutics, Inc., an emerging leader in ... present new results on its antiviral program to ... the PML Consortium (composed of Pfizer, Bristol-Meyers Squibb, ... the causative agent of Progressive Multifocal Leukoencephalopathy (PML). ... extended release formulation, can clear JC polyomavirus (JCV) ...
Breaking Medicine Technology:BioElectronics and Pulsed Shortwave Therapy Make Progress 2Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML) 2
... Announces Clinical Trial Plans for 4Q07/1Q08, DALLAS, ... ACCP) provided today an update on the clinical,development ... prodrug, and,announced plans for additional human clinical trials ... ongoing clinical trial in recurrent ovarian,cancer patients, designed ...
... ... Study -, ... has initiated a multi-dose, Phase 2a clinical trial with,its monoclonal antibody ... dose-escalation study is,designed to evaluate the safety and tolerability of multiple ...
Cached Medicine Technology:Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac 2Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac 3Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac 4MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma 2
... The Accustrip Strep A(ll) Test ... immunoassay for the rapid, qualitative ... antigen from throat swabs. The ... as an aid in the ...
HemataSTAT II has a manual reader. It uses both 0.5 and 1.1 ID capillary tubes., , Spins in just 60 seconds , Built-in reader with LCD display , Accuracy comparable to NCCLS reference method , Lid lo...
The INRatio meter is a diagnostic Point Of Care system that provides Prothrombin Time (PT) and International Normalized Ratio (INR) results using one drop of fresh capillary whole blood from a finger...
The Osteomark NTx Point of Care (POC)device allows physicians to monitor their patients response to anti-resorptive drugs as early as 3-6 months from starting treatment. Osteomark NTx shows you and y...
Medicine Products: